Loading...

Loading...

J&J’s Acquisition, Research, Women’s Health: The Week in Health
By Sofía Garduño - Thu, 03/14/2024 - 10:00
The week in health includes J&J acquiring Ambrx Biopharma, BD researching Peripheral Arterial Disease, and a focus on women's health.
https://mexicobusiness.news/tag/cervical-cancer
More Health
Global Commitment: US$600M Pledged to Eradicate Cervical Cancer
By Anmol Motwani - Fri, 03/08/2024 - 10:18
Governments and donors pledge nearly $600M at Cervical Cancer Elimination Forum to scale up prevention and adopt one-dose HPV strategy.

HPV Risk Gender Gap: Elevated Concerns for Women
By Sofía Garduño - Thu, 02/29/2024 - 17:19
The heightened risk for women upon HPV infection underscores the importance of regular Pap smear screenings.
Cervical Cancer Awareness Month: A Crucial Global Initiative
By Sofía Garduño - Tue, 01/23/2024 - 13:01
Cervical Cancer Awareness Month stresses early detection, treatment, and HPV vaccination for the fourth most common cancer in women.
The Cancellation of Health Norms and Possible Consequences
By Rafael Gual - Tue, 07/11/2023 - 15:00
The government has canceled 34 norms related to health, without explanation, a move that could have a serious impact, writes Rafael Gual.
IMSS-Bienestar, INSP Celebrate Actions to Strengthen Healthcare
By Sofía Garduño - Thu, 02/02/2023 - 10:00
IMSS-Bienestar is investing in health infrastructure. Meanwhile, the INSP celebrates its 36th year supporting the public health sector.
Cervical Cancer: The Fourth Most Common Cancer Among Women
By Sofía Garduño - Fri, 01/27/2023 - 11:21
The WHO plans to eliminate cervical cancer by 2030 through HPV vaccination and other measures.
Women Deserve an Improved Cervical Cancer Test: Hera Diagnostics
By Sofía Garduño - Mon, 11/14/2022 - 14:00
In two thirds of the world, cervical cancer screens have poor accuracy, generate anxiety and may cause bleeding. HeraFem solves those problems.
Shining a Light on Cervical Cancer
By - Wed, 09/05/2018 - 17:08
Onko Solutions México is a Mexican startup that commercializes Truscreen, a medical device for the detection of cervical cancer.